ATERAterian, Inc.

Nasdaq aterian.io


$ 2.89 $ -0.11 (-3.68 %)    

Thursday, 01-Aug-2024 15:55:16 EDT
QQQ $ 457.29 $ -11.41 (-2.42 %)
DIA $ 403.27 $ -5.26 (-1.29 %)
SPY $ 541.71 $ -7.80 (-1.42 %)
TLT $ 95.61 $ 0.50 (0.53 %)
GLD $ 225.83 $ -0.78 (-0.34 %)
$ 2.88
$ 2.94
$ 2.83 x 100
$ 2.89 x 100
$ 2.82 - $ 2.94
$ 1.90 - $ 6.54
41,116
na
24.29M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-19-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-16-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aterian-boosts-q2-net-revenue-outlook-from-20m---23m-to-23m---26m-est-21633m

The Company today also announced an update to its previously stated Adjusted EBITDA loss to be in the range of ($1.0) million t...

 aterian-names-arturo-rodriguez-as-ceo-josh-feldman-as-cfo

Joe Risico has resigned as Co-CEO and from the Board of Directors and will consult the Company over a three month transition pe...

 alliance-global-partners-upgrades-aterian-to-buy

Alliance Global Partners analyst Brian Kinstlinger upgrades Aterian (NASDAQ:ATER) from Neutral to Buy.

 aterian-affirms-2h24-adjusted-ebitda-profitability-target-sees-q2-net-revenue-of-20m-23m-est-21656m

For the second quarter 2024, taking into account the current global environment and inflation, we believe that net revenue will...

 aterian-q1-2024-gaap-eps-076-beats-112-estimate-sales-20214m-beat-19445m-estimate

Aterian (NASDAQ:ATER) reported quarterly losses of $(0.76) per share which beat the analyst consensus estimate of $(1.12) by 32...

 aterian-expects-q1-revenue-of-200m-210m-prior-180m-210m-vs-1945m-est

Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company") today announced updates to its previously announced ne...

 aterian-expands-reach-begins-selling-on-mercado-libre-marketplace-in-mexico

Aterian revealed partnership with Mercado Libre, tapping into Latin America's e-commerce boom. Aterian begins selling home ...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 why-lifecore-biomedical-shares-are-trading-lower-by-around-32-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it con...

 why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION